Autism and Cord Blood Stem Cells: FDA Gives Green Lite for Groundbreaking Clinical Trial
August 21, 2012
MultiVu / Powered by NewsLook.com
Sutter Neuroscience Institute, a recognized Center of Excellence, and CBR (Cord Blood Registry), the world's largest stem cell bank, are launching the first FDA- approved clinical trial to assess the use of a child's own cord blood stem cells to treat select patients with autism. This first-of-its-kind placebo controlled study will evaluate the ability of an infusion of cord blood stem cells to help improve language and behavior. The study is in conjunction with the Sutter Institute for Medical Research.
FORA.tv (Mar. 10, 2013) The Hidden Universality of Food Allergy
Gluten Free Society - Humble Civic Center
Dr. Russell M. Jaffe is Lab Director of ELISA/ACT Biotechnologies LLC and Fellow of the Health Studies Collegium. ... watch video
Reuters - Innovations Video Online (Feb. 4, 2014) Researchers at the Mayo Clinic are preparing to test their theory that stem cells grow faster in microgravity. With a grant from an organization that promotes research aboard the International Space ... watch video
Reuters (Oct. 31, 2013) Researchers in the US are developing a medical implant that can communicate with cells and organs deep inside the human body using lite. The research represents a significant achievement in the ... watch video
Reuters (Apr. 9, 2013) Doctors at Emory University in the US are testing a new stem cell therapy for people with severe arthritis. They hope that by harvesting stem cells from a patient, the potent cells will regenerate ... watch video
Newsy (May 15, 2014) The mice were given human stem cells to test stem cell rejection. But instead of rejecting the human cells, the mice began to show positive reactions.
Video provided by ... watch video
Reuters (Dec. 27, 2012) Chinese scientists from the Guangzhou Institutes of Biomedicine and Health have converted cells found in urine into pluripotent stem cells that can be used to create neurons and brain cells. The ... watch video
Reuters (Dec. 22, 2013) Scientists in New York have successfully turned human stem cells into functional lung and airway cells for the first time. It's a breakthrough the researchers at Columbia University believe could ... watch video
Newsy (Oct. 25, 2014) A Harvard University Research Team created genetically engineered stem cells that are able to kill cancer cells, while leaving other cells unharmed.
Video provided by ... watch video
July 30, 2015 Numerous genes that regulate the activity of a neurotransmitter in the brain have been found to be abundant in brain tissue of depressed females. This could be an underlying cause of the higher ... read more
July 30, 2015 A new study helps explain why the candidate vaccine used in the HVTN 505 clinical trial was not protective against HIV infection despite robustly inducing anti-HIV antibodies: the vaccine stimulated ... read more
July 30, 2015 It is possible to predict the timing and intensity of influenza outbreaks in subtropical climates like Hong Kong where flu seasons can occur at different times and more than once during a year, ... read more
July 30, 2015 Researchers report that they have designed a cheap prosthetic knee that mimics normal walking motion. The team reports that it has calculated the ideal torque that a prosthetic knee should produce, ... read more
July 30, 2015 Researchers have reconstructed an ancient virus that is highly effective at delivering gene therapies to the liver, muscle, and retina. This discovery could potentially be used to design gene ... read more
Aug. 11, 2014 A clinical trial to investigate the safety of neural stem cell transplantation in patients with chronic spinal cord injuries has been launched in the United States. Related goals of the clinical ... read more
Dec. 9, 2013 Donated umbilical cord blood contains stem cells that can save the lives of leukemia and lymphoma patients. A multi-center study has found that growing cord blood stem cells in a laboratory before ... read more
Dec. 12, 2011 A therapy involving a natural compound may improve the ability of stem cells from umbilical cord blood to engraft in patients receiving a stem cell transplant for cancer or other diseases, a phase I ... read more